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Abstract
Objetive: The aim of this study was to determine erbB expression in normal mucosa, oral dysplasia, and invasive 
carcinomas developed in the hamster’s buccal pouch chemical carcinogenesis model. 
Study design: Fifty Syrian golden hamsters were equally divided in five groups (A-E); two controls and three experi-
mental group exposed to alcohol, DMBA, or both for 14 weeks. Number of tumors per cheek, volume, histological 
condition, erbB expression were determined and results were analyzed by the Mann–Whitney U and Dunn’s test. 
Results: Control groups and those exposed to alcohol (A, B and C respectively) only presented clinical and histo-
logical normal mucosa; while those exposed to DMBA or DMBA plus alcohol (D and E groups) developed dys-
plasia and invasive carcinomas. erbB2, erbB3, and erbB4 increased their expression in alcohol-exposed mucosa, 
dysplasia, and invasive carcinomas. We observed a similar expression level for erbB2 in dysplasia and carcinomas; 
while, erbB3 and erbB4 were similar only in carcinomas. 
Conclusion: The DMBA and alcohol can be considered as carcinogen and promoter for oral carcinogenesis. The 
erbB expression is different according to their histological condition, suggesting differential participation of the 
erbB family in oral carcinogenesis induced by alcohol and DMBA. 
Key words: erbB, 7,12- dimethylbenz(a)anthracene, oral squamous cell carcinoma.
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Introduction
Worldwide, approximately 274,300 new cases and 127,500 
deaths have been attributed to oral cancer during 2002 (1). 
Oral squamous cell carcinoma (OSCC) is the most fre-
quent neoplasm in the mouth, and many OSCC are preced-
ed by leukoplakia and erythroplakia, which could present 
epithelial dysplasia (ED), an indicative of malignancy de-
velopment (2). 7,12-dimethylbenz(a)anthracene (DMBA), 
a polycyclic aromatic hydrocarbon has been found in high 
concentration (40-100 ng per cigarette) in the tar fraction of 
cigarette smoke (3). In mammalian cells, DMBA is bioac-
tivated to the diol-epoxide metabolite, which subsequently 
promotes adducts to adenine and guanine residues in DNA 
(4). Another important compound is the ethanol, however, 
the ethanol carcinogenic effect is controversial; some re-
ports consider it as co-carcinogen and/or tumor promoter 
(5, 6). Nevertheless, ethanol consumption has been associ-
ated to a 2- to 3-fold increased risk for cancer in the oral 
cavity, pharynx, larynx, and esophagus (7). 
The cellular and molecular analysis, had improve our 
understanding of OSCC. The analysis of the tyrosine 
kinase erbB family receptors (erbB1/EGFR, erbB2/
Neu/HER2, erbB3/HER3, and erbB4/HER4) had in-
dicated their participation in embryogenesis, prolifera-
tion, differentiation, and malignant transformation of 
breast, renal, colon, and oral cancer. These receptors 
are activated upon ligand-induced receptor dimeriza-
tion and, consequently, numerous dimmers are formed, 
promoting downstream transduction pathway activa-
tion, such as MAPK, PI3K, and STAT (8). erbB1 and 
erbB2 over-expression plays a significant role in driving 
cancer cells through the cell cycle checkpoints in G1-S 
transition. erbB2, erbB3, and erbB4 signaling has been 
associated with apoptosis evasion, invasion, metas-
tases to lymph nodes and angiogenesis (9,10). Specific 
determination of erbB expression to each tumor could 
improve our understanding of their biological behavior. 
Our hypothesis is that erbB receptor expression changes 
is according to histological condition, for that reason, 
the aim of this study was to determine the relationship 
of erbB expression in normal mucosa, dysplasia, and 
invasive carcinomas developed in the hamster buccal 
pouch chemical carcinogenesis model.
Material and Methods
-Population, clinical and histological analysis
Fifty male Syrian golden hamsters (Mesocricetus au-
ratus), 5-week-old, were employed following the guide-
lines of the Ethics committee of the Postgraduate and 
Research Division, Dental School, National Autono-
mous University of México. All animals were housed 
at four animals per cage, with 12 h light:dark cycles. 
At 8-week-old animals were divided randomly in five 
groups; ten animals for each group (A to E groups). The 
weight of each animal was measured weekly. Animals 
from group A remained untreated while those in group 
B received mineral oil (Sigma-Aldrich, M8410, St. Lou-
is, MO) on the right cheek pouch applied three times per 
week during fourteen weeks at 10 a.m., using a camel’s 
hair brush No. 4. The animals from groups C and E were 
left to consume ethanol solution at 15% (Mallinckrodt 
Baker, V568, Xalostoc, Mexico) ad libitum, consump-
tion was measured two times per week. Groups D and E 
received DMBA (Sigma-Aldrich, D3254) at 0.5%, dis-
solved in mineral oil, as above. The amount of carcino-
gens delivered to each animal was quite uniform using 
the ‘‘wiped-brush’’ method (11). All animals were si-
multaneously sedated and killed by a chloroform over-
dose (Sigma-Aldrich, C2432). The right cheek pouch 
was dissected and washed in Hank’s balanced salt so-
lution (Gibco-BRL, Cat. 0-125 Pailey, Scotland, UK). 
Tumor per cheek pouch and two diameters from each 
tumor were registered. Tumor volume was calculated 
through diameter measures and the equation V = a x b2 
x 0.52; where a is the largest diameter and b is the larg-
est diameter perpendicular to a (12). The cheek pouch 
was divided in two halves; a portion was fixed in 4% 
paraformaldehyde solution for 24 h for its histological 
and immunohistochemical analysis. Another portion 
was immediately frozen in liquid nitrogen and stored at 
-80ºC until their western blot analysis.
The fixed samples were processed for paraffin embed-
ding, 4 µm serial sections, and hematoxylin and eosin 
staining for histopathological analysis was made. The 
histological classification in normal mucosa, epithelial 
dysplasia (ED; mild, moderate and severe), and OSCC 
(well differentiated, WD; moderately differentiated, 
MD and poorly differentiated, PD) was performed by 
an oral pathologist.
-Western blot (WB) analysis
Frozen samples were homogenized and lysed in 300 µl 
of lysis buffer (225 mM saccharose, 10 mM Tris, 0.3 
mM ethylene glycol tetraacetic acid, 1% Triton X-100, 2 
mM sodium orthovanadate, 10 mM sodium fluoride, 1 
mM sodium carbonate; and a mixture of proteinase in-
hibitors, including 1 mM phenymethylsulfonyl fluoride, 
10 µg/ml aprotinin, 5 µg/ml leupeptin, 5 mM benza-
midine, 10 µg/ml phenantrholine; BD, Bioscience Phar-
migen). Tissue lysate was cleared by centrifugation at 
10,000 rpm at 4ºC for 10 minutes. Protein content was 
quantified using Lowry’s protein assay (13). Protein (25 
µg) was electrophoresed in a 10% gradient SDS-PAGE 
for 120 minutes at 150 mV. The resolved protein was 
transferred to nitrocellulose membranes (Bio-Rad, Her-
cules, CA).  The membrane was blocked with PBS-1% 
Triton with 5% non-fat dry milk for  2 h for posterior 
overnight primary antibodies incubation (erbB1, sc-
03, rabbit polyclonal, 1:1000; erbB2, sc-7301, mouse 
monoclonal, 1:1000; erbB3, sc-285, rabbit polyclonal, 
1:1500, and erbB4, sc-283, rabbit polyclonal, 1:1000, all 
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antibodies from Santa Cruz Biotechnology, Santa Cruz, 
CA) in heat sealed plastic bags at 4ºC. Horseradish per-
oxidase-labeled (goat anti-mouse sc-2005, mouse anti-
rabbit, sc-2357, mouse anti-goat, sc-2354, Santa Cruz 
Biotechnology) secondary antibodies were used for 1 
h at room temperature incubation. The immune com-
plex was visualized using the ECL Western blot detec-
tion system (Amersham Pharmacia Biotech, Arlington 
Heights, IL) according to manufacturer’s instruction. 
Membranes were exposed one minute to Kodak Bi-
omax light film (Eastman Kodak, Co., Rochester, NY). 
ß-actin and GAPDH (Sigma A1978, mouse monoclonal, 
IgG1, 1:2000 and sc-20357 goat polyclonal, 1:1500, 
Santa Cruz Biotechnology, respectively) detection was 
used as charge control. The film was scanned for den-
sitometric analysis using Scion Image software (Scion, 
Frederick, MD). Each representative sample according 
to histological condition was analyzed in triplicate.
-Immunohistochemistry (IHC)
The IHC analysis for erbB1, erbB2, erbB3, and erbB4 
was performed according to reported (14). Eight slides 
for each sample were deparaffinized and rehydrated 
in xylene and alcohol washes. Antigenic retrieval in 
10 mM citrate buffer; endogenous peroxidase block-
ade in 3% hydrogen peroxide, unspecific blockade 
with serum-free protein block (DakoCytomation, 
Dako, Carpinteria, CA) and posterior immersion in 
0.2% Triton X100 were performed. Four slides were 
incubated overnight with anti-erbB primary antibod-
ies at 4°C in 1:100 dilution.  Biotinylated link uni-
versal secondary antibody and streptavidin-HRP in-
cubation for 30 minute each were performed (Dako, 
Carpinteria, CA). Posterior 3,3’diaminobenzidine 
revealing (Dakocytomation, Dako, Carpinteria, CA) 
and Hill’s hematoxylin nuclear counterstaining were 
done, for posterior dehydration in alcohol-xylene se-
rial washes and mounting with hydrophobic resin 
(14). For negative control (the rest four slides), the 
primary antibody was substituted by phosphate buff-
er saline (PBS) solution. From each slide, a digital 
photomicrograph of 2000 × 1500 pixels was obtained 
at 1000X magnification with a digital camera (Olym-
pus C-3040 Tokyo, Japan). Cellular expression zone 
was determined semiquantitatively as follows: zone 
(membrane, cytoplasm, and nucleus) and percentage 
of positive cells (0 = 0% cells, 1 = 1 to 29% cells, 2 = 
30 to 69% cells, and 3 = >70 % cells).
-Statistical analysis
All data are presented as means ± SE. Mean values were 
analyzed by ANOVA with a post hoc Mann–Whitney U 
and Dunn’s test to compare differences between groups 
and similar histological conditions. Statistical signifi-
cance was at P < 0.05, SPSS v.13.0. Software package 
(SPSS Inc., Chicago IL) was used for statistical analysis.
Results
-Clinical and histological analysis
The final population was 47 hamsters; in groups D and 
E two and one animal were lost by territorial disputes, 
respectively. The mean weight of all specimens was of 
99.2 ± 6.6 g, none important variation was observed. 
The alcohol consumption for C and E groups was 20.4 
± 2ml and 18.9 ± 2.3ml, respectively. In clinical exam-
ination, only D and E groups developed tumors. The 
number of tumors per cheek in D group was of 3.2 ± 
1.7 with a mean volume of 15.4 ± 9.8 mm3; animals of 
group E showed 2 ± 0.7 tumors with a mean volume of 
84.6 ± 44.9 mm3. 
The histological analyses indicate that all specimens of 
A, B, and C groups showed normal mucosa. Group D 
showed four specimens diagnosed as severe ED and 4 
WD OSCC. The E group presented two specimens clas-
sified as severe ED, 5 WD OSCC, one MD OSCC and 
one PD OSCC.
-erbB expression
The WB analysis indicates that erbB1 did not present 
changes in expression in normal mucosa of groups A, 
B, and C. The severe ED and WD OSCC developed 
in D and E groups revealed noticeable variation be-
tween similar histological condition and comparing to 
control normal mucosa. erbB2 showed a significant in-
crease (P = 0.04) in alcohol-exposed mucosa compare 
to control normal mucosa. In severe ED showed simi-
lar expression patterns, while WD OSCC of E group 
showed significant increase. erbB3 presented signifi-
cant changes in alcohol-exposed mucosa (P = 0.01), 
severe ED and WD OSCC compare to control; since, 
only severe ED showed significant difference between 
similar histological condition. erbB4 showed varia-
tion in severe ED and WD OSCC compare to control; 
since, comparing similar histological condition only 
severe ED showed significant variation in their expres-
sion (Table 1), (Fig. 1).
-Cellular expression zone 
To determine the cellular expression zone IHC analy-
sis was performed. We observed that erbB1 in normal 
mucosa (A to C groups) was expressed predominant-
ly in membrane, however, severe ED and all OSCC 
showed differential expression patterns compare to 
normal mucosa and between similar histological con-
ditions. erbB2 presented cytoplasm expression in all 
normal mucosa and increase their membrane expres-
sion in severe ED and WD carcinoma, with a similar 
expression pattern between similar histological con-
dition. erbB3 and erbB4 presented variation in alco-
hol-exposed mucosa, severe ED and WD carcinomas 
compared to control normal mucosa, and differential 
expression between similar histological condition 
(Table 2), (Fig. 1).
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Table 1. erbB expression analysis according their histological condition.
erbB expression analysis by histological condition in A to E groups. The alcohol exposed normal mucosa showed significant increase of erbB2 and 
erbB3. The severe ED only shows significant change in erbB3, important variation of erbB1 and erbB4, and similar erbB2 expression. The well 
differentiated carcinomas (WD OSCC) showed significant difference in erbB1 and similar expression for the other receptors. The moderately and 
poorly differentiated carcinomas show variation in erB1 and erbB3. ED= epithelial dysplasia, WD= well differentiated, MD= moderately differenti-
ated, PD= poorly differentiated and OSCC= oral squamous cell carcinoma.*Statistical significance p≤ 0.05. Dunn’s test.
Normal 
mucosa-A 
Normal 
mucosa-B 
Normal 
mucosa-C 
Severe ED-
D
Severe ED-
E
WD
OSCC-D 
WD
OSCC-E 
MD OSCC-
E
PD OSCC-E 
erbB1 87.2±15.2 90.13±17.9 90.1±18.2 40.2±8.5* 98.1±27.9 81.1±13. 6* 48.3±8.1* 89.1±25.1 65.1±16.3 
Vs to control 
(A) 
 NS NS P=0.04 NS NS P=0.03 NA NA 
Vs to similar 
histological 
condition
NS P=0.03 P=0.02 NA 
erbB2 20.2±8.2 28.8±7.9 78.3±16.6* 45.2±19.4 39.3±18.5 50.1±29.2 76.9±13.2 89.9±25.8 94.9±16.7 
Vs to control 
(A) 
 NS P=0.04 NS NS NS P=0.02 NA NA 
Vs to similar 
histological 
condition
P=0.04 NS NS NA 
erbB3 24.7±5.3 19.2±7.8 81.1±8.4* 100.1±19.5* 54.1±7.3 97.4±15.4 117.1±16.2 84.1±9.1 38.2±8.2 
Vs to control 
(A) 
 NS P=0.01 P=0.03 NS P=0.03 P=0.04 NA NA 
Vs to similar 
histological 
condition
P=0.01 P=0.02 NS NA 
erbB4 50.9±15.8 63.7±12.2 98.2±26.5 90.2±18.6 48.1±7.5 95.3±15.4 127.4±27.9 77.4±37.1 73.4±19.3 
Vs to control 
(A) 
 NS NS P=0.03 NS P=0.03 P=0.02 NA NA 
Vs to similar 
histological 
condition
NS P=0.02 NS NA 
?
Discussion
Alcohol and tobacco consumption are very common 
in some areas of the world, this behavior increases the 
relative risk to develop larynx, pharynx, esophagus, 
and oral cancer (3-6,15). We confirm above, when ob-
served that alcohol, DMBA and both exposure induced 
clinical, histological, and molecular alterations related 
to oral carcinogenesis. DMBA is an organ-specific car-
cinogen, which can mediate neoplasm transformation 
by inducing DNA damage, generating excess reactive 
oxygen species, mediate the chronic inflammatory 
process and tumor develop (16). Our results from D and 
E groups are according with that above, however, the 
tumors developed in animals receiving DMBA and al-
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Fig. 1. Expression of erbB family members in oral carcinogenesis. 
a) Western Blot analysis according to histological condition. erbB1 
showed similar expression for normal mucosa (1 to 3) and differ-
ent expression for severe ED and carcinomas. erbB2 increase their 
expression in alcohol exposed mucosa, severe ED and carcinomas. 
1) Normal mucosa group A, 2) Normal mucosa group B, 3) Normal 
mucosa group C, 4) Severe ED group D, 5) Severe ED group E, 6) 
WD OSCC group D, 7) WD OSCC group E, 8) MD OSCC group E 
and 9) PD OSCC group E.
b) IHC analysis. a) erbB1 expression in normal mucosa with pre-
dominant membrane expression pattern b) erbB1 in WD OSCC of 
group D with cytoplasm expression pattern, c) erbB2 expression in 
normal mucosa of group A showed cytoplasm expression pattern 
without presence in corneous stratum, d) erbB2 expression in WD 
OSCC of group D with cytoplasm expression pattern even in cells 
next to keratinization area, e) erbB3 expression in normal mucosa, f) 
erbB3 expression in alcohol exposed mucosa, it shows an important 
expression increase, g) and h) showed similar expression pattern of 
erbB4 in WD carcinomas of D and E groups. Objective 100X. Scale 
bar = 8 µm
Table 2. erbB expression according to their cellular zone.
Cellular zone 
expression
Normal 
mucosa 
(A)
Normal 
mucosa 
(B)
Normal 
mucosa 
(C)
Severe 
ED (D)
Severe 
ED (E)
WD 
OSCC 
(D)
WD 
OSCC 
(E)
MD 
OSCC 
(E)
PD 
OSCC 
(E)
erbB1
M 3 3 3 1 2 1 0 2 0
C 1 1 1 3 2 3 3 2 3
N 0 0 0 0 0 0 0 0 0
erbB2
M 0 0 0 1 1 1 1 0 0
C 3 3 3 3 3 3 3 3 3
N 0 0 0 0 0 0 0 0 0
erbB3
M 0 0 1 0 2 2 0 0 0
C 3 3 3 3 2 2 3 3 3
N 0 0 0 0 0 0 0 0 0
erbB4
M 0 0 2 2 1 1 1 0 1
C 3 3 2 2 3 3 3 3 3
N 0 0 0 0 0 0 0 0 0
Analysis of erbB cellular zone expression showed that alcohol exposed mucosa change erbB3 and erbB4 expression in cellular membrane. The severe 
ED obtained in D and E groups, showed similar erbB2 zone expression and of erbB1, erbB3 and erbB4. The well differentiated carcinomas developed 
in D and E groups, showed similar expression in erbB2 and erbB4 and variation of erbB1 and erbB 3. The moderately differentiated and poorly 
OSCC presented similar expression of erbB2 and erbB3 (M: Membrane, C: Cytoplasm and N: Nucleus).
cohol (group E) were bigger than those from animals 
receiving only DMBA (D group); this would be associ-
ated to alcohol’s promoter effect (17). Nevertheless, the 
promoter effect of alcohol is controversial, some reports 
attribute this to its metabolic product, acetaldehyde, 
because that interferes with DNA synthesis and repair, 
induces point mutation, sister chromatin exchanges, 
and chromosomal aberration (5, 18). Another possible 
promoter effect derived from alcohol is the increase in 
mucosa’s permeability to toxic and carcinogenic com-
pounds, it has been reported that diluted ethanol (15%) 
may be more effective than higher concentration of eth-
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anol, because, this concentration allows molecules and 
compounds to cross the membrane (19). Both possible 
effects could induced malignant transformation, how-
ever to confirm the malignant phenotype a histological 
analysis is required. The histological analysis of A, B 
and C groups showed normal mucosa, D group devel-
oped severe ED and WD carcinoma, whereas group E 
also presented ED, however, invasive carcinoma was 
the predominant histological condition. This could be 
compared to patients that consume both compounds, 
in whom the relative risk to develop oral carcinomas is 
higher with ethanol and tobacco consumption (15). The 
golden Syria Hamster chemical oral carcinogenesis is a 
model that closely resembles a human oral tumor, both 
histologically and morphologically. Lipid peroxidation, 
epigenetic control, angiogenesis and apoptosis had been 
analyzed; however, the implication of an important re-
ceptor family, as erbB, during sequential pathogenesis 
of this model had not been reported (16,20-22).
The role of erbB receptors in carcinogenesis has been 
established in breast, colon, lung cancer, and head and 
neck carcinoma. Their expression and function analy-
sis is an important research issue because the possible 
approaches could be applied in specific therapies (10). 
Our results indicate that erbB1 showed similar level and 
pattern expression in normal mucosa; and variations 
in its level and zone expression in severe dysplasia and 
invasive carcinomas developed in D and E groups. The 
above suggest that erbB1 expression is necessary in his-
tological normal condition, but when an early or severe 
malignant transformation is present the level and cellular 
zone expression can modify. An interesting feature was 
the change in expression zone of membrane to cytoplasm 
in dysplasia and carcinomas as compared to normal mu-
cosa. Lin et al. have reported that erbB can translocate 
from membrane to nucleus promoting transcription, and 
enhancing malignant transformation (23). It is possible 
that this effect is carrying out, nevertheless, to determi-
nate what are the particular mechanism involved, tran-
scription or proteomic analysis is necessary.
Some reports suggest that only erbB1 and erbB2 are 
sufficient to induce cell transformation, however, others 
indicate that erbB3 and erbB4 could participate (24-26). 
Our results suggest an increase in erbB2, erbB3, and 
erbB4 expression in alcohol exposed mucosa, severe 
ED and invasive OSCC compared to control normal 
mucosa. It has been reported that perturbation in epi-
thelial permeability barrier leads to increasing mRNA 
levels of IL-1a, IL-1b, TNFa, and GM-CSF, as well as 
in the inflammatory response. The increase of erbB re-
ceptors could be a response mechanism that promotes 
epithelial maintenance, repair, differentiation, and en-
hancement of survival in exposed cells, however, if a 
carcinogen appears the malignant transformation could 
be more possible (19,27).
In our experimental model erbB2 showed level expres-
sion increase in alcohol exposed mucosa, severe ED and 
carcinomas, with similar membrane cellular expression 
only for severe ED and well differentiated OSCC. This 
result agrees with the report by Fong et al., which in-
dicated that erbB2 expression in normal mucosa was 
almost undetectable, very low in ED, and significantly 
higher in OSCC, suggesting the participation of this re-
ceptor in early transformation (26). Respect to erbB3 a 
similar level expression pattern to erbB2 was observed 
in alcohol exposed mucosa, severe ED and carcinomas; 
however, in their cellular zone expression a heterogene-
ous pattern was observed. Xia et al. have reported that 
principally erbB2 and erbB3 expression to be associated 
to malignant phenotype, suggesting that these receptors 
may help predict the outcome of patients with OSCC 
(25). However, our results in this animal model suggest 
that erbB4 and erbB2 are the predominant receptors in 
well differentiated OSCC. These changes could be deri-
vate from reduction of erbB1 expression, heterogeneous 
erbB3 expression and molecular structure of erbB4. The 
role of erbB4 in neoplasm biology is controversial, be-
cause some reports suggest a protector action for this 
receptor and other consider it as an indicator of aggres-
siveness and metastasis (24,25,28-30). Today, the gold-
en Syrian hamster model is an important tool in the oral 
cancer research; nevertheless, the compare to human 
cancer is necessary, in our opinion this is the principal 
limitation of that experimental model. Until one does 
not demonstrate similarities between both carcinogenic 
processes, the applications will be reduced.
The understanding of cellular and molecular carcino-
genesis, could give to us the possibility of restrain the 
advance of malignant transformation using specific 
inhibitors, monoclonal antibodies or chemopreventive 
compounds directed to erbB2, erbB3 or erbB4. The 
above means a promising advance in oral oncology be-
cause currently many young people consume ethanol, 
tobacco or both and the oral cancer risk is increasing. 
In this study we observe the carcinogenic potential of 
DMBA, the promoter effect of ethanol and the particular 
behavior of erbB receptors, suggesting a homogenous 
pattern for erbB2 and erbB4 in well differentiated car-
cinomas. The underlying revelation of the mechanism 
involved is necessary to lead to the application of new 
therapeutic strategies derived from this knowledge.
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